Cardio Diagnostics announced that it received a notification letter from the Listing Qualifications Department of Nasdaq notifying the company that it had regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CDIO: